CARBOCYCLIC THROMBOXANE A2

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C22H36O3
Molecular Weight	348.5194
Optical Activity	UNSPECIFIED
Defined Stereocenters	5 / 5
E/Z Centers	2
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCCC[C@H](O)\C=C\[C@H]1C[C@H]2C[C@H](C2)[C@@H]1C\C=C/CCCC(O)=O

InChI

InChIKey=ZIWNJZLXPXFNGN-JJPTUHNDSA-N

InChI=1S/C22H36O3/c1-2-3-6-9-20(23)13-12-18-14-17-15-19(16-17)21(18)10-7-4-5-8-11-22(24)25/h4,7,12-13,17-21,23H,2-3,5-6,8-11,14-16H2,1H3,(H,24,25)/b7-4-,13-12+/t17-,18-,19+,20-,21+/m0/s1

HIDE SMILES / InChI

Molecular Formula	C22H36O3
Molecular Weight	348.5194
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	5 / 5
E/Z Centers	2
Optical Activity	UNSPECIFIED

Approval Year

PubMed

Title	Date	PubMed
Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.	1992-07	1434130

Patents

Substance Class	Chemical Created by `admin` on `Wed Apr 02 11:36:51 GMT 2025` Edited by `admin` on `Wed Apr 02 11:36:51 GMT 2025`
Record UNII	0K593AJ3OL
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CARBOCYCLIC THROMBOXANE A2

Common Name

English

CARBOCYCLIC TXA2

Preferred Name

English

THROMBOXANE A2, CARBOCYCLIC

Common Name

English

CTA2

Common Name

English

5-HEPTENOIC ACID, 7-((2S,3R)-3-((1E,3S)-3-HYDROXY-1-OCTEN-1-YL)BICYCLO(3.1.1)HEPT-2-YL)-, (5Z)-

Systematic Name

English

Code System Code Type Description

FDA UNII

0K593AJ3OL

Created by admin on Wed Apr 02 11:36:51 GMT 2025 , Edited by admin on Wed Apr 02 11:36:51 GMT 2025

PRIMARY

EPA CompTox

DTXSID90995350

Created by admin on Wed Apr 02 11:36:51 GMT 2025 , Edited by admin on Wed Apr 02 11:36:51 GMT 2025

PRIMARY

CAS

74034-56-3

Created by admin on Wed Apr 02 11:36:51 GMT 2025 , Edited by admin on Wed Apr 02 11:36:51 GMT 2025

PRIMARY

CHEBI

139043

Created by admin on Wed Apr 02 11:36:51 GMT 2025 , Edited by admin on Wed Apr 02 11:36:51 GMT 2025

PRIMARY